{"id":"W2286173468","doi":"10.1200/jco.2015.63.8049","title":"Pointed Progress in Second-Line Advanced Non–Small-Cell Lung Cancer: The Rapidly Evolving Field of Checkpoint Inhibition","year":2016,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"European Society for Medical Oncology; AstraZeneca Canada; American Society of Clinical Oncology","keywords":"Medicine; Cancer; Cancer research; Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001973834,0.0002751348,0.003692503,0.0002397602,0.00003337646,0.000007399086,0.000197831,0.0006257258,0.0005292534],"category_scores_gemma":[0.001051559,0.0001335174,0.001222871,0.0002522803,0.0001489062,0.00009755189,0.00006775235,0.001409488,0.000005025023],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005856696,"about_ca_system_score_gemma":0.006025604,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001806362,"about_ca_topic_score_gemma":0.0001229872,"domain_scores_codex":[0.9946053,0.0004406094,0.00418172,0.0002544612,0.000258717,0.0002591815],"domain_scores_gemma":[0.9909738,0.00284677,0.005120401,0.0002808272,0.0005854932,0.0001926701],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000466099,0.0009368202,0.001141444,0.004422588,0.0007742358,0.0002525806,0.0001081383,0.000001055792,0.000004440541,0.000008171875,0.001437432,0.990447],"study_design_scores_gemma":[0.01421336,0.0091076,0.001788745,0.06020055,0.006077711,0.0003203107,0.0001102286,0.00003360483,0.00007127265,0.0000664951,0.9077687,0.0002414068],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004050564,0.9877017,0.00009148844,0.003750896,0.00139562,0.00121839,0.00002710278,0.000006001085,0.001758301],"genre_scores_gemma":[0.004453206,0.9919846,0.001106678,0.0005710863,0.001112373,0.00009824242,0.00001202901,0.00003545385,0.0006263554],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9902056,"threshold_uncertainty_score":0.9996093,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06750101670510644,"score_gpt":0.5144393905794349,"score_spread":0.4469383738743284,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}